ArticleCancer science2021

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells.

Yoshifumi Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.